About the NIH Clinical Center

NIH Clinical Trials Search Page

Return to NIH Listings Menu

Non-NIH Trial Listings

Research centers specializing in this illness area

Additional resources in this illness area

NIH Studies: Cardiology/Vascular Diseases

Below is a listing of government-funded clinical trials in Cardiology/Vascular Diseases, being conducted by the various National Institutes of Health at the Warren Grant Magnuson Clinical Center in Bethesda, MD.

Click on a study summary to view the study description and contact information directly from the NIH's web site.

[*]Nitrite as a Marker of Cardiovascular Risk; Development of Novel Biomarkers in Patients with Coronary Artery Disease

[*]Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging

[*]A Pilot Study of Fractionated Dose Subcutaneous Rituximab (RTX, Rituxan® (Registered Trademark)) in Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia

[*]Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Systemic Nitrite Infusion

[*]The Treatment of Deep Vein Thrombosis of the Lower Extremities with "Low-Dose" Alteplase

[*]Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients

[*]Technical Development of Cardiovascular MRI in Patients

[*]Predicting Response to Cardiac Resynchronization Therapy in Heart Failure

[*]A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study

[*]Treatment of Jugular, Subclavian, and/or Innominate Vein Thrombosis with Low Dose Recombinant Tissue Plasminogen Activator plus Anticoagulation.

[*]Cardiovascular Magnetic Resonance Imaging of Pediatric Normal Volunteers

[*]Relationship of Diastolic Function and Functional Capacity in Hypertrophic Cardiomyopathy: a Post-Hoc Analysis of Protocols 01-H-0066 and 96-H-0144

[*]Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy

[*]Dose-Response Study of Modulation of Gene Expression in Peripheral Blood Mononuclear Cells by Atorvastatin

[*]Genetic Analysis of African-American Hypertensives

[*]Cardiovascular Evaluation of Patients with Familial Hypercholesterolemia and Normal Individuals

[*]Modulation of Vascular Endothelial Growth Factor (VEGF) Using and Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication

[*]Pilot Study of T-Cell-Depleted Peripheral Blood Stem Cell Transplantation from Partially Matched Related Donors for Patients with High-Risk Leukemia

[*]Heart Disease Risk Factors in African Americans

[*]The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study

[*]Real-Time MRI-Guided Percutaneous Intervention for Aorto-illac and Femoropopliteal, Artery Stenosis

[*]Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients with Coronary Artery Disease

[*]Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples from Patients with Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members

[*]Characterization of Cardiac Function in Patients with Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I

[*]Technical Development of Strain Rate Echocardiography

[*]Utilization of Cardiac Magnetic Resonance Imaging in Evaluation of Patients with Heart Disease not Eligible for Current Cardiac Energetics Research Protocols (A Teaching Protocol)

[*]Evaluation of Patients with Heart Disease Not Eligible for Research Protocols

[*]Evaluation of Patients with Known or Suspected Heart Disease (Screening Protocol)

[*]A Randomized Study of Three Immunosuppressive Regimens in Treatment Naive Patients with Severe Aplastic Anemia: Horse-ATG/CsA Taper vs Rabbit-ATG/CsA vs Alemtuzumab

[*]Effects of Dark Chocolate Consumption on Insulin Sensitivity and Capillary Recruitment in Subjects with Essential Hypertension

Last updated: September 15, 2006 at 4:30:37 PM


Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA